UNSPSC 51172171: Eperisone hydrochloride

This classification denotes an anticholinergic agent with the molecular formula C17H25NO.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U38O8U7P6X, chemically known as 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, hydrochloride but more generally known as eperisone hydrochloride, which bears US NIH Compound Identifier 123698. European Medicines Agency schedules Eperisone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01900MIG.

Most nations, for tariff and trade purposes, schedule eperisone hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, EPERISONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Eperisone hydrochloride bears US NLM NCI C83693. SMILES: CCC1CCC(CC1)C(=O)C(C)CN2CCCCC2.CL.

UNSPSC 51172171 Eperisone hydrochloride, a Commodity code, shows limited alignment with recent state and local procurement activity. The code nominally names a pharmaceutical compound used as a muscle relaxant, yet the sole recent opportunity posted under it—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—involves laboratory testing infrastructure, staffing, and analytical chemistry services rather than the purchase or supply of eperisone hydrochloride itself. The mismatch suggests either miscoding by the issuing body or a data classification artifact. State and local buyers have not recently solicited eperisone hydrochloride as a standalone pharmaceutical input under this code identifier.

The Collin County RFP, due July 23, 2026, sought proposals to operate two collection sites in Plano and McKinney, administer randomized testing notifications via Interactive Voice Response, perform immunoassay screening with confirmatory testing (LC/MS/MS or GC/MS), and offer alternative methodologies including oral fluid and hair analysis. The estimated contract value is $600,000 over two years with three optional one-year renewals, not to exceed five years total. The vendor must hold lab certification from SAMHSA, TX DPS, or CAP, submit per-test pricing for three service models (screening only, confirmation after screening, or screening with automatic confirmation), and absorb all freight, delivery, insurance, and staffing costs with no additional surcharges. Funding comes from Texas Department of Criminal Justice-Community Justice Assistance Division appropriations, subject to annual availability. The anticipated award date was August 10, 2026. Beyond this single opportunity, the code shows no recent activity among state agencies, counties, cities, school districts, transit authorities, or other state and local issuing bodies.